We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

InVivo Therapeutics Receives Approval for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury

News   Apr 10, 2013

 
InVivo Therapeutics Receives Approval for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury
 
 
 

RELATED ARTICLES

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

New Clues on Stem Cell Transplant Rejection Revealed

News

A study by researchers at UCSF has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.

READ MORE

Lung Cell Transplant Boosts Healing After the Flu

News

Some cases of the flu are so severe they cause lasting injury to the lungs. New research from the University of Pennsylvania now points to a strategy that may one day offer protection against this damage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE